Biomerica, Inc., a global provider of innovative diagnostic solutions, announced that its Fortel Prostate Specific Antigen (PSA) Screening Test has received approval from the United Arab Emirates Ministry of Health and Prevention (MOHAP).
Biomerica is a California-based biomedical company that develops and manufactures diagnostic and therapeutic products for gastrointestinal and inflammatory diseases.